Citations 23

Kinetic Analysis of Interaction of BRCA1 Tandem Breast Cancer C-Terminal Domains with Phosphorylated Peptides Reveals Two Binding Conformations

Biochemistry | August 22, 2008 | Volume: 47 | Issue: 37 | Pages: 9866-9879

10.1021/bi702247d | PMID 18717574

Interaction of AsymmetricABCC9-Encoded Nucleotide Binding Domains Determines KATPChannel SUR2A Catalytic Activity

Journal of Proteome Research | March 1, 2008 | Volume: 7 | Issue: 4 | Pages: 1721-1728

10.1021/pr7007847 | PMID 18311911

The BRCT Domain Is a Phospho-Protein Binding Domain

Science | October 23, 2003 | Volume: 302 | Issue: 5645 | Pages: 639-642

10.1126/science.1088753 | PMID 14576433

The carboxyl-terminal domain (BRCT) of the Breast Cancer Gene 1 (BRCA1) protein is an evolutionarily conserved module that exists in a large number of proteins from prokaryotes to eukaryotes. Although most BRCT domain–containing proteins participate in DNA-damage checkpoint or DNA-repair pathways, or both, the function of the BRCT domain is not fully understood. We show that the BRCA1 BRCT domain directly interacts with phosphorylated BRCA1-Associated Carboxyl-terminal Helicase (BACH1). This specific interaction between BRCA1 and phosphorylated BACH1 is cell cycle regulated and is required for DNA damage–induced checkpoint control during the transition from G 2 to M phase of the cell cycle. Further, we show that two other BRCT domains interact with their respective physiological partners in a phosphorylation-dependent manner. Thirteen additional BRCT domains also preferentially bind phospho-peptides rather than nonphosphorylated control peptides. These data imply that the BRCT domain is a phospho-protein binding domain involved in cell cycle control.